Shares

10 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Jul 12, 2022

SELL
$153.1 - $216.76 $59,862 - $84,753
-391 Closed
0 $0
Q1 2022

Apr 22, 2022

BUY
$170.79 - $256.31 $66,778 - $100,217
391 New
391 $83,000
Q4 2021

Jan 28, 2022

SELL
$249.49 - $325.25 $148,945 - $194,174
-597 Closed
0 $0
Q3 2021

Oct 26, 2021

SELL
$282.94 - $341.0 $28,294 - $34,100
-100 Reduced 14.35%
597 $172,000
Q2 2021

Jul 28, 2021

SELL
$245.66 - $320.13 $71,487 - $93,157
-291 Reduced 29.45%
697 $216,000
Q1 2021

Apr 30, 2021

SELL
$241.17 - $318.09 $219,223 - $289,143
-909 Reduced 47.92%
988 $258,000
Q4 2020

Jan 27, 2021

BUY
$258.87 - $308.55 $472,437 - $563,103
1,825 Added 2534.72%
1,897 $516,000
Q3 2020

Oct 08, 2020

BUY
$240.77 - $297.07 $17,335 - $21,389
72 New
72 $20,000
Q2 2020

Jul 10, 2020

SELL
$150.11 - $239.1 $46,083 - $73,403
-307 Closed
0 $0
Q1 2020

Apr 17, 2020

BUY
$120.93 - $164.97 $37,125 - $50,645
307 New
307 $48,000

Others Institutions Holding VEEV

About VEEVA SYSTEMS INC


  • Ticker VEEV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Health Information Services
  • Shares Outstandng 140,516,000
  • Market Cap $31.5B
  • Description
  • Veeva Systems Inc. provides cloud-based software for the life sciences industry in North America, Europe, the Asia Pacific, the Middle East, Africa, and Latin America. The company offers Veeva Commercial Cloud, a suite of software, data, and analytics solutions, which include Veeva customer relationship management (CRM) and Veeva Medical CRM, Ve...
More about VEEV
Track This Portfolio

Track Exane Derivatives Portfolio

Follow Exane Derivatives and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Exane Derivatives, based on Form 13F filings with the SEC.

News

Stay updated on Exane Derivatives with notifications on news.